The Brilliant Medical Career Of Dr. Cameron Clokie

Dr. Cameron Clokie is a maxillofacial and oral surgeon, a serial entrepreneur, a scientist, and he works for Induce Biologics, Incorporated as the CEO. Induce Biologics specializes in regenerative medicine with their focus on finding innovative solutions regarding musculoskeletal reconstruction. Dr. Clokie spent thirty years in the field of clinical practice and academic dentistry on BizCommunity.com. In 1998 her was named as the Head of Maxillofacial and Oral Surgery. He stayed with the University of Toronto until he retired from the academic field in 2017. He has also served on the scientific advisory boards for numerous companies.

Dr. Cameron Clokie has had a substantial number of papers published and made presentations internationally and nationally regarding regenerative medicine and bone reconstruction. Dr. Clokie holds 25 international and United States patents either pending or existing. Many of these relate to bone healing. He is responsible for the development of strategic alliances with numerous businesses and has transferred his ingenuity and knowledge into enterprises that are commercially viable.

Read more: Cameron Clokie DDS, Ph.D.: Executive Profile & Biography

By the end of the 1990’s, Dr. Cameron Clokie wanted to test bone morphogenetic proteins also referred to as BMP’s. This was an effective tool in jaw surgery although a lot of bone was required. In 1999 he repaired the first jawbone using BMP. The legs and arms of forty cadavers were ground to acquire three milligrams of BMP. This source was not approved which led Dr. Clokie to a U.S. biotech company able to produce BPM out of Chinese hamsters. He has performed the procedure with the use of this source and oral surgeons in South Africa are now trying this procedure as well.

Dr. Clokie is currently planning to generate BMP with the insertion of the human gene it is produced by into the embryos of goats. This could produce large quantities of BPM in the milk of the goats. Montreal biotech used a similar technology when they inserted the silk producing gene of a spider into the embryo of a goat. The goat was placed in a herd with the result being the mass production of spider silk protein to be used by the industrial and medical fields. Dr. Clokie is now trying to find a way to lower the resultant costs.

Learn more about Cameron Clokie: http://www.fsnhospitals.com/profiles/dr-cameron-clokie